Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic

To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2020-12, Vol.158 (6), p.2502-2510
Hauptverfasser: Kouri, Andrew, Gupta, Samir, Yadollahi, Azadeh, Ryan, Clodagh M., Gershon, Andrea S., To, Teresa, Tarlo, Susan M., Goldstein, Roger S., Chapman, Kenneth R., Chow, Chung-Wai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2510
container_issue 6
container_start_page 2502
container_title Chest
container_volume 158
creator Kouri, Andrew
Gupta, Samir
Yadollahi, Azadeh
Ryan, Clodagh M.
Gershon, Andrea S.
To, Teresa
Tarlo, Susan M.
Goldstein, Roger S.
Chapman, Kenneth R.
Chow, Chung-Wai
description To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective measurements of lung function will alter the diagnosis and care of patients with chronic respiratory diseases. PFT, which includes spirometry, lung volume, and diffusion capacity measurement, is essential to the diagnosis and management of patients with asthma, COPD, and other chronic lung conditions. Both traditional and innovative alternatives to conventional testing must now be explored. These may include peak expiratory flow devices, electronic portable spirometers, portable exhaled nitric oxide measurement, airwave oscillometry devices, and novel digital health tools such as smartphone microphone spirometers and mobile health technologies along with integration of machine learning approaches. The adoption of some novel approaches may not merely replace but could improve existing management strategies and alter common diagnostic paradigms. With these options comes important technical, privacy, ethical, financial, and medicolegal barriers that must be addressed. However, the coronavirus disease 19 pandemic also presents a unique opportunity to augment conventional testing by including innovative and emerging approaches to measuring lung function remotely in patients with respiratory disease. The benefits of such an approach have the potential to enhance respiratory care and empower patient self-management well beyond the current global pandemic.
doi_str_mv 10.1016/j.chest.2020.06.065
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7345485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0012369220318675</els_id><sourcerecordid>2423056512</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-53cd5de8d4a798c3b3428c77604b7ffd60c4abcab31830f4d38ab2fb78a017cb3</originalsourceid><addsrcrecordid>eNp9UdtKJDEQDeKi4-ULBOlHX3rMvbsfFLzvwsAOy_gccmvN0J1o0i3495t2RnFfFgqKSp06p1IHgBME5wgifr6e62ebhjmGGM4hz8F2wAw1BJWEUbILZhAiXBLe4H1wkNIa5ho1fA_sE8wZhg2bgeWVMdGm5PxT8ceaUVtTLKQKUQ4hvpfXMuWH5dj1wcv4XtyPXg8u-GKVlaeZ2zFOSRZL6Y3tnT4CP1rZJXu8zYfg8f5udfOzXPx--HVztSg1w2woGdGGGVsbKqum1kQRimtdVRxSVbWt4VBTqbRUBNUEttSQWircqqqWEFVakUNwueF9GVVvjbZ-iLITL9H1eVERpBP_drx7Fk_hTVSEMlqzTHC2JYjhdczfEb1L2nad9DaMSWCKCWScIZyhZAPVMaQUbfslg6CYvBBr8eGFmLwQkOeYBE6_b_g183n8DLjYAGy-05uzUSTtrM8WuGj1IExw_xX4C-cbnbE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2423056512</pqid></control><display><type>article</type><title>Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kouri, Andrew ; Gupta, Samir ; Yadollahi, Azadeh ; Ryan, Clodagh M. ; Gershon, Andrea S. ; To, Teresa ; Tarlo, Susan M. ; Goldstein, Roger S. ; Chapman, Kenneth R. ; Chow, Chung-Wai</creator><creatorcontrib>Kouri, Andrew ; Gupta, Samir ; Yadollahi, Azadeh ; Ryan, Clodagh M. ; Gershon, Andrea S. ; To, Teresa ; Tarlo, Susan M. ; Goldstein, Roger S. ; Chapman, Kenneth R. ; Chow, Chung-Wai</creatorcontrib><description>To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective measurements of lung function will alter the diagnosis and care of patients with chronic respiratory diseases. PFT, which includes spirometry, lung volume, and diffusion capacity measurement, is essential to the diagnosis and management of patients with asthma, COPD, and other chronic lung conditions. Both traditional and innovative alternatives to conventional testing must now be explored. These may include peak expiratory flow devices, electronic portable spirometers, portable exhaled nitric oxide measurement, airwave oscillometry devices, and novel digital health tools such as smartphone microphone spirometers and mobile health technologies along with integration of machine learning approaches. The adoption of some novel approaches may not merely replace but could improve existing management strategies and alter common diagnostic paradigms. With these options comes important technical, privacy, ethical, financial, and medicolegal barriers that must be addressed. However, the coronavirus disease 19 pandemic also presents a unique opportunity to augment conventional testing by including innovative and emerging approaches to measuring lung function remotely in patients with respiratory disease. The benefits of such an approach have the potential to enhance respiratory care and empower patient self-management well beyond the current global pandemic.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1016/j.chest.2020.06.065</identifier><identifier>PMID: 32652095</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>asthma ; Asthma - diagnosis ; Asthma - physiopathology ; Asthma - therapy ; Breath Tests - instrumentation ; Breath Tests - methods ; Chronic Disease ; COPD ; COVID-19 ; COVID-19 pandemic ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - therapy ; Delivery of Health Care - methods ; Education and Clinical Practice: CHEST Reviews ; Humans ; Hypertension, Pulmonary - diagnosis ; Hypertension, Pulmonary - therapy ; Inventions ; Lung Diseases - diagnosis ; Lung Diseases - physiopathology ; Lung Diseases - therapy ; Lung Diseases, Interstitial - diagnosis ; Lung Diseases, Interstitial - therapy ; Lung Volume Measurements ; Machine Learning ; Oscillometry - instrumentation ; Oscillometry - methods ; Peak Expiratory Flow Rate ; Pulmonary Diffusing Capacity - instrumentation ; Pulmonary Diffusing Capacity - methods ; Pulmonary Disease, Chronic Obstructive - diagnosis ; Pulmonary Disease, Chronic Obstructive - physiopathology ; Pulmonary Disease, Chronic Obstructive - therapy ; pulmonary function test ; Respiratory Function Tests - instrumentation ; Respiratory Function Tests - methods ; review ; SARS-CoV-2 ; Self-Management ; Smartphone ; Spirometry - instrumentation ; Spirometry - methods</subject><ispartof>Chest, 2020-12, Vol.158 (6), p.2502-2510</ispartof><rights>2020 American College of Chest Physicians</rights><rights>Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</rights><rights>2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. 2020 American College of Chest Physicians</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-53cd5de8d4a798c3b3428c77604b7ffd60c4abcab31830f4d38ab2fb78a017cb3</citedby><cites>FETCH-LOGICAL-c525t-53cd5de8d4a798c3b3428c77604b7ffd60c4abcab31830f4d38ab2fb78a017cb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32652095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kouri, Andrew</creatorcontrib><creatorcontrib>Gupta, Samir</creatorcontrib><creatorcontrib>Yadollahi, Azadeh</creatorcontrib><creatorcontrib>Ryan, Clodagh M.</creatorcontrib><creatorcontrib>Gershon, Andrea S.</creatorcontrib><creatorcontrib>To, Teresa</creatorcontrib><creatorcontrib>Tarlo, Susan M.</creatorcontrib><creatorcontrib>Goldstein, Roger S.</creatorcontrib><creatorcontrib>Chapman, Kenneth R.</creatorcontrib><creatorcontrib>Chow, Chung-Wai</creatorcontrib><title>Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic</title><title>Chest</title><addtitle>Chest</addtitle><description>To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective measurements of lung function will alter the diagnosis and care of patients with chronic respiratory diseases. PFT, which includes spirometry, lung volume, and diffusion capacity measurement, is essential to the diagnosis and management of patients with asthma, COPD, and other chronic lung conditions. Both traditional and innovative alternatives to conventional testing must now be explored. These may include peak expiratory flow devices, electronic portable spirometers, portable exhaled nitric oxide measurement, airwave oscillometry devices, and novel digital health tools such as smartphone microphone spirometers and mobile health technologies along with integration of machine learning approaches. The adoption of some novel approaches may not merely replace but could improve existing management strategies and alter common diagnostic paradigms. With these options comes important technical, privacy, ethical, financial, and medicolegal barriers that must be addressed. However, the coronavirus disease 19 pandemic also presents a unique opportunity to augment conventional testing by including innovative and emerging approaches to measuring lung function remotely in patients with respiratory disease. The benefits of such an approach have the potential to enhance respiratory care and empower patient self-management well beyond the current global pandemic.</description><subject>asthma</subject><subject>Asthma - diagnosis</subject><subject>Asthma - physiopathology</subject><subject>Asthma - therapy</subject><subject>Breath Tests - instrumentation</subject><subject>Breath Tests - methods</subject><subject>Chronic Disease</subject><subject>COPD</subject><subject>COVID-19</subject><subject>COVID-19 pandemic</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - therapy</subject><subject>Delivery of Health Care - methods</subject><subject>Education and Clinical Practice: CHEST Reviews</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - diagnosis</subject><subject>Hypertension, Pulmonary - therapy</subject><subject>Inventions</subject><subject>Lung Diseases - diagnosis</subject><subject>Lung Diseases - physiopathology</subject><subject>Lung Diseases - therapy</subject><subject>Lung Diseases, Interstitial - diagnosis</subject><subject>Lung Diseases, Interstitial - therapy</subject><subject>Lung Volume Measurements</subject><subject>Machine Learning</subject><subject>Oscillometry - instrumentation</subject><subject>Oscillometry - methods</subject><subject>Peak Expiratory Flow Rate</subject><subject>Pulmonary Diffusing Capacity - instrumentation</subject><subject>Pulmonary Diffusing Capacity - methods</subject><subject>Pulmonary Disease, Chronic Obstructive - diagnosis</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>pulmonary function test</subject><subject>Respiratory Function Tests - instrumentation</subject><subject>Respiratory Function Tests - methods</subject><subject>review</subject><subject>SARS-CoV-2</subject><subject>Self-Management</subject><subject>Smartphone</subject><subject>Spirometry - instrumentation</subject><subject>Spirometry - methods</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UdtKJDEQDeKi4-ULBOlHX3rMvbsfFLzvwsAOy_gccmvN0J1o0i3495t2RnFfFgqKSp06p1IHgBME5wgifr6e62ebhjmGGM4hz8F2wAw1BJWEUbILZhAiXBLe4H1wkNIa5ho1fA_sE8wZhg2bgeWVMdGm5PxT8ceaUVtTLKQKUQ4hvpfXMuWH5dj1wcv4XtyPXg8u-GKVlaeZ2zFOSRZL6Y3tnT4CP1rZJXu8zYfg8f5udfOzXPx--HVztSg1w2woGdGGGVsbKqum1kQRimtdVRxSVbWt4VBTqbRUBNUEttSQWircqqqWEFVakUNwueF9GVVvjbZ-iLITL9H1eVERpBP_drx7Fk_hTVSEMlqzTHC2JYjhdczfEb1L2nad9DaMSWCKCWScIZyhZAPVMaQUbfslg6CYvBBr8eGFmLwQkOeYBE6_b_g183n8DLjYAGy-05uzUSTtrM8WuGj1IExw_xX4C-cbnbE</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Kouri, Andrew</creator><creator>Gupta, Samir</creator><creator>Yadollahi, Azadeh</creator><creator>Ryan, Clodagh M.</creator><creator>Gershon, Andrea S.</creator><creator>To, Teresa</creator><creator>Tarlo, Susan M.</creator><creator>Goldstein, Roger S.</creator><creator>Chapman, Kenneth R.</creator><creator>Chow, Chung-Wai</creator><general>Elsevier Inc</general><general>American College of Chest Physicians. Published by Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201201</creationdate><title>Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic</title><author>Kouri, Andrew ; Gupta, Samir ; Yadollahi, Azadeh ; Ryan, Clodagh M. ; Gershon, Andrea S. ; To, Teresa ; Tarlo, Susan M. ; Goldstein, Roger S. ; Chapman, Kenneth R. ; Chow, Chung-Wai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-53cd5de8d4a798c3b3428c77604b7ffd60c4abcab31830f4d38ab2fb78a017cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>asthma</topic><topic>Asthma - diagnosis</topic><topic>Asthma - physiopathology</topic><topic>Asthma - therapy</topic><topic>Breath Tests - instrumentation</topic><topic>Breath Tests - methods</topic><topic>Chronic Disease</topic><topic>COPD</topic><topic>COVID-19</topic><topic>COVID-19 pandemic</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - therapy</topic><topic>Delivery of Health Care - methods</topic><topic>Education and Clinical Practice: CHEST Reviews</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - diagnosis</topic><topic>Hypertension, Pulmonary - therapy</topic><topic>Inventions</topic><topic>Lung Diseases - diagnosis</topic><topic>Lung Diseases - physiopathology</topic><topic>Lung Diseases - therapy</topic><topic>Lung Diseases, Interstitial - diagnosis</topic><topic>Lung Diseases, Interstitial - therapy</topic><topic>Lung Volume Measurements</topic><topic>Machine Learning</topic><topic>Oscillometry - instrumentation</topic><topic>Oscillometry - methods</topic><topic>Peak Expiratory Flow Rate</topic><topic>Pulmonary Diffusing Capacity - instrumentation</topic><topic>Pulmonary Diffusing Capacity - methods</topic><topic>Pulmonary Disease, Chronic Obstructive - diagnosis</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>pulmonary function test</topic><topic>Respiratory Function Tests - instrumentation</topic><topic>Respiratory Function Tests - methods</topic><topic>review</topic><topic>SARS-CoV-2</topic><topic>Self-Management</topic><topic>Smartphone</topic><topic>Spirometry - instrumentation</topic><topic>Spirometry - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kouri, Andrew</creatorcontrib><creatorcontrib>Gupta, Samir</creatorcontrib><creatorcontrib>Yadollahi, Azadeh</creatorcontrib><creatorcontrib>Ryan, Clodagh M.</creatorcontrib><creatorcontrib>Gershon, Andrea S.</creatorcontrib><creatorcontrib>To, Teresa</creatorcontrib><creatorcontrib>Tarlo, Susan M.</creatorcontrib><creatorcontrib>Goldstein, Roger S.</creatorcontrib><creatorcontrib>Chapman, Kenneth R.</creatorcontrib><creatorcontrib>Chow, Chung-Wai</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kouri, Andrew</au><au>Gupta, Samir</au><au>Yadollahi, Azadeh</au><au>Ryan, Clodagh M.</au><au>Gershon, Andrea S.</au><au>To, Teresa</au><au>Tarlo, Susan M.</au><au>Goldstein, Roger S.</au><au>Chapman, Kenneth R.</au><au>Chow, Chung-Wai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>158</volume><issue>6</issue><spage>2502</spage><epage>2510</epage><pages>2502-2510</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><abstract>To reduce the spread of the severe acute respiratory syndrome coronavirus 2, many pulmonary function testing (PFT) laboratories have been closed or have significantly reduced their testing capacity. Because these mitigation strategies may be necessary for the next 6 to 18 months to prevent recurrent peaks in disease prevalence, fewer objective measurements of lung function will alter the diagnosis and care of patients with chronic respiratory diseases. PFT, which includes spirometry, lung volume, and diffusion capacity measurement, is essential to the diagnosis and management of patients with asthma, COPD, and other chronic lung conditions. Both traditional and innovative alternatives to conventional testing must now be explored. These may include peak expiratory flow devices, electronic portable spirometers, portable exhaled nitric oxide measurement, airwave oscillometry devices, and novel digital health tools such as smartphone microphone spirometers and mobile health technologies along with integration of machine learning approaches. The adoption of some novel approaches may not merely replace but could improve existing management strategies and alter common diagnostic paradigms. With these options comes important technical, privacy, ethical, financial, and medicolegal barriers that must be addressed. However, the coronavirus disease 19 pandemic also presents a unique opportunity to augment conventional testing by including innovative and emerging approaches to measuring lung function remotely in patients with respiratory disease. The benefits of such an approach have the potential to enhance respiratory care and empower patient self-management well beyond the current global pandemic.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32652095</pmid><doi>10.1016/j.chest.2020.06.065</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2020-12, Vol.158 (6), p.2502-2510
issn 0012-3692
1931-3543
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7345485
source MEDLINE; Alma/SFX Local Collection
subjects asthma
Asthma - diagnosis
Asthma - physiopathology
Asthma - therapy
Breath Tests - instrumentation
Breath Tests - methods
Chronic Disease
COPD
COVID-19
COVID-19 pandemic
Cystic Fibrosis - diagnosis
Cystic Fibrosis - therapy
Delivery of Health Care - methods
Education and Clinical Practice: CHEST Reviews
Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - therapy
Inventions
Lung Diseases - diagnosis
Lung Diseases - physiopathology
Lung Diseases - therapy
Lung Diseases, Interstitial - diagnosis
Lung Diseases, Interstitial - therapy
Lung Volume Measurements
Machine Learning
Oscillometry - instrumentation
Oscillometry - methods
Peak Expiratory Flow Rate
Pulmonary Diffusing Capacity - instrumentation
Pulmonary Diffusing Capacity - methods
Pulmonary Disease, Chronic Obstructive - diagnosis
Pulmonary Disease, Chronic Obstructive - physiopathology
Pulmonary Disease, Chronic Obstructive - therapy
pulmonary function test
Respiratory Function Tests - instrumentation
Respiratory Function Tests - methods
review
SARS-CoV-2
Self-Management
Smartphone
Spirometry - instrumentation
Spirometry - methods
title Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A59%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Addressing%20Reduced%20Laboratory-Based%20Pulmonary%20Function%20Testing%20During%20a%20Pandemic&rft.jtitle=Chest&rft.au=Kouri,%20Andrew&rft.date=2020-12-01&rft.volume=158&rft.issue=6&rft.spage=2502&rft.epage=2510&rft.pages=2502-2510&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1016/j.chest.2020.06.065&rft_dat=%3Cproquest_pubme%3E2423056512%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2423056512&rft_id=info:pmid/32652095&rft_els_id=S0012369220318675&rfr_iscdi=true